These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 23428998

  • 1. Increased benefit of alteplase in patients with ischemic stroke and a high body temperature.
    de Ridder I, den Hertog H, van Gemert M, Dippel D, van der Worp B, PAIS investigators.
    Cerebrovasc Dis; 2013; 35(1):60-3. PubMed ID: 23428998
    [Abstract] [Full Text] [Related]

  • 2. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 3. Low body temperature does not compromise the treatment effect of alteplase.
    Lees JS, Mishra NK, Saini M, Lyden PD, Shuaib A, Virtual International Stroke Trials Archive (VISTA) Collaborators.
    Stroke; 2011 Sep; 42(9):2618-21. PubMed ID: 21757664
    [Abstract] [Full Text] [Related]

  • 4. Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 °C or above.
    de Ridder IR, de Jong FJ, den Hertog HM, Lingsma HF, van Gemert HM, Schreuder AH, Ruitenberg A, Maasland EL, Saxena R, Oomes P, van Tuijl J, Koudstaal PJ, Kappelle LJ, Algra A, van der Worp HB, Dippel DW.
    Int J Stroke; 2015 Apr; 10(3):457-62. PubMed ID: 23692587
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M, Diener HC, Kaste M, Mau J.
    Cerebrovasc Dis; 2007 Apr; 24(4):349-54. PubMed ID: 17690547
    [Abstract] [Full Text] [Related]

  • 6. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial.
    den Hertog HM, van der Worp HB, van Gemert HM, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ, Dippel DW, PAIS Investigators.
    Lancet Neurol; 2009 May; 8(5):434-40. PubMed ID: 19297248
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
    Mori E, Minematsu K, Nakagawara J, Yamaguchi T, Japan Alteplase Clinical Trial (J-ACT) Group.
    J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):517-22. PubMed ID: 20719535
    [Abstract] [Full Text] [Related]

  • 9. The effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in daily practice.
    Dirks M, Niessen LW, van Wijngaarden J, Koudstaal PJ, Franke CL, van Oostenbrugge RJ, Dippel DW, PRACTISE investigators.
    Int J Stroke; 2012 Jun; 7(4):289-92. PubMed ID: 22168317
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal.
    Jones ML, Holmes M.
    Health Technol Assess; 2009 Sep; 13 Suppl 2():15-21. PubMed ID: 19804685
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
    Prescrire Int; 2004 Aug; 13(72):127-31. PubMed ID: 15532135
    [Abstract] [Full Text] [Related]

  • 17. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B, Sun XJ, Ju CH.
    Eur Neurol; 2011 Aug; 65(3):170-4. PubMed ID: 21372577
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
    Ciccone A, Valvassori L, Nichelatti M, SYNTHESIS Expansion investigators.
    Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
    Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, O'Brien B, Bladin C, McElduff P, Allen C, Bateman G, Donnan G, Davis S, Levi C.
    N Engl J Med; 2012 Mar 22; 366(12):1099-107. PubMed ID: 22435369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.